National Cancer Center, Cancer Information Service. https://ganjoho.jp/reg_stat/statistics/data/dl/index.html#a14. Accessed 24 Apr 2023
Giovannucci E, Rimm EB, Colditz GA, Stampfer MJ, Ascherio A, Chute CG, et al. A prospective study of dietary fat and risk of prostate cancer. J Natl Cancer Inst. 1993;85(19):1571–9.
Article CAS PubMed Google Scholar
Moraes FY, Siqueira GM, Abreu CE, da Silva JL, Gadia R. Hypofractioned radiotherapy in prostate cancer: is it the next step? Expert Rev Anticancer Ther. 2014;14(11):1271–6.
Quan EM, Li X, Li Y, Wang X, Kudchadker RJ, Johnson JL, et al. A comprehensive comparison of IMRT and VMAT plan quality for prostate cancer treatment. Int J Radiat Oncol Biol Phys. 2012;83(4):1169–78.
Article PubMed PubMed Central Google Scholar
Arya R, Goyal H, Naik A, Gurjar OP. A prospective observational study to analyse the influence of bladder and rectal volume changes on prostate radiotherapy using IMRT. Rep Pract Oncol Radiother. 2020;25(3):312–7.
Article PubMed PubMed Central Google Scholar
Williams MJ, Bailey M, Forstner D, Metcalfe PE. Multicentre quality assurance of intensity-modulated radiation therapy plans: a precursor to clinical trials. Australas Radiol. 2007;51(5):472–9.
Article CAS PubMed Google Scholar
Xu Y, Brovold N, Cyriac J, Bossart E, Padgett K, Butkus M, et al. Assessment of knowledge-based planning for prostate intensity modulated proton therapy. Int J Part Ther. 2021;8(2):62–72.
Article PubMed PubMed Central Google Scholar
Hirashima H, Nakamura M, Mukumoto N, Ashida R, Fujii K, Nakamura K, et al. Reducing variability among treatment machines using knowledge-based planning for head and neck, pancreatic, and rectal cancer. J Appl Clin Med Phys. 2021;22(7):245–54.
Article PubMed PubMed Central Google Scholar
Fusella M, Scaggion A, Pivato N, Rossato MA, Zorz A, Paiusco M. Efficiently train and validate a RapidPlan model through APQM scoring. Med Phys. 2018;45(6):2611–9.
Perumal B, Sundaresan HE, Ranganathan V, Ramar N, Anto GJ, Meher SR. Evaluation of plan quality improvements in PlanIQ-guided autoplanning. Rep Pract Oncol Radiother. 2019;24(6):533–43.
Article PubMed PubMed Central Google Scholar
Sasaki M, Ikushima H, Tominaga M, Kamomae T, Kishi T, Oita M, et al. Dose impact of rectal gas on prostatic IMRT and VMAT. Jpn J Radiol. 2015;33(12):723–33.
Ahmed S, Nelms B, Gintz D, Caudell J, Zhang G, Moros EG, et al. A method for a priori estimation of best feasible DVH for organs-at-risk: validation for head and neck VMAT planning. Med Phys. 2017;44(10):5486–97.
Article CAS PubMed Google Scholar
Fried DV, Chera BS, Das SK. Assessment of PlanIQ Feasibility DVH for head and neck treatment planning. J Appl Clin Med Phys. 2017;18(5):245–50.
Article PubMed PubMed Central Google Scholar
Shimizu H, Sasaki K, Aoyama T, Iwata T, Kitagawa T, Kodaira T. Lung dose reduction in patients with stage III non-small-cell lung cancer using software that estimates patient-specific dose reduction feasibility. Phys Med. 2021;85:57–62.
Nelms BE, Robinson G, Markham J, Velasco K, Boyd S, Narayan S, et al. Variation in external beam treatment plan quality: an inter-institutional study of planners and planning systems. Pract Radiat Oncol. 2012;2(4):296–305.
Sasaki M, Nakaguuchi Y, Kamomae T, Tsuzuki A, Kobuchi S, Kuwahara K, et al. Analysis of prostate intensity- and volumetric-modulated arc radiation therapy planning quality with PlanIQ™. J Appl Clin Med Phys. 2021;22(4):132–42.
Article PubMed PubMed Central Google Scholar
Kang Z, Fu L, Liu J, Shi L, Li Y. A practical method to improve the performance of knowledge-based VMAT planning for endometrial and cervical cancer. Acta Oncol. 2022;61(8):1012–8.
Article CAS PubMed Google Scholar
Hussein M, South CP, Barry MA, Adams EJ, Jordan TJ, Stewart AJ, et al. Clinical validation and benchmarking of knowledge-based IMRT and VMAT treatment planning in pelvic anatomy. Radiother Oncol. 2016;120(3):473–9.
Kubo K, Monzen H, Ishii K, Tamura M, Kawamorita R, Sumida I, et al. Dosimetric comparison of RapidPlan and manually optimized plans in volumetric modulated arc therapy for prostate cancer. Phys Med. 2017;44:199–204.
Comments (0)